Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Investigation of Cell-Contact Dependent Alterations in Immune Synapse Formation between T Cells and BCP-ALL Cells

Britta Wenske, PhD, Lothar Marischen, PhD, Julia Welzenbach, André Heimbach, PhD, Per Hoffmann, PhD, Selim Corbacioglu, MD, David A Williams, MD, Anja Troeger, MD

Blood (2019) 134 (Supplement_1): 2754.

https://doi.org/10.1182/blood-2019-128835

Published: 2019

Journal Articles

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

Jennifer Puck, MD

Blood (2017) 130 (Supplement 1): SCI-30.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-30.SCI-30

Published: 2017

Journal Articles

Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation

Peter J. Siska, MD, J. Brice Weinberg, MD, Arati V. Rao, MD, James R. Bain, PhD, Michael J. Muehlbauer, PhD, Tingyu Liu, Jeffrey Rathmell, PhD

Blood (2014) 124 (21): 4121.

https://doi.org/10.1182/blood.V124.21.4121.4121

Published: 2014

Journal Articles

Hydroxyurea Is Most Suitable for Cytoreduction of AML Prior to CD33/CD3 Bispecific BiTE® Antibody (AMG 330) Therapy: Uncompromised T-Cell Proliferation Ex-Vivo and CD33 Upregulation on AML Cells

Christina Krupka, Franziska Brauneck, Felix S Lichtenegger, MD, Peter Kufer, MD, Roman Kischel, MD, Gerhard Zugmaier, Thomas Köhnke, MD, Torben Altmann, MD, Stephanie Schneider, PhD, Michael Fiegl, MD, Karsten Spiekermann, MD, Angus M Sinclair, PhD, Kathryn J Newhall, PhD, Stanley R Frankel, MD, Patrick Baeuerle, PhD, Wolfgang Hiddemann, MD, Gert Riethmüller, MD, Marion Subklewe, MD

Blood (2014) 124 (21): 986.

https://doi.org/10.1182/blood.V124.21.986.986

Published: 2014

Journal Articles

Immunological Effects and Predictive Gene Signatures in Patients with Relapsed Follicular Lymphoma Treated with CT-011, a Humanized Anti-PD-1 Monoclonal Antibody

Fuliang Chu, PhD, Jason R. Westin, MD, Min Zhang, Ph.D., Lei Feng, Veerabhadran Baladandayuthapani, PhD, Zhiqiang Wang, Rochelle Allen, RN, Michael Wallace, MD, Luis Vence, Laszlo Radvanyi, Larry W. Kwak, MD, PhD, Rinat Rotem-Yehudar, PhD, R Eric Davis, Sattva S. Neelapu, MD

Blood (2012) 120 (21): 162.

https://doi.org/10.1182/blood.V120.21.162.162

Published: 2012

Journal Articles

Inhibitory Ligands CD200, CD270, CD274 and CD276 Are Expressed On Eμ-TCL1 Transgenic Mouse Splenocytes and Are of Potential Relevance to Impaired T-Cell Function in Vivo

Fabienne McClanahan, MD, Cristina Ghirelli, PhD, Paul Greaves, MD, John C. Riches, MD, Rita Coutinho, MD, Alan G. Ramsay, PhD, John G Gribben

Blood (2012) 120 (21): 313.

https://doi.org/10.1182/blood.V120.21.313.313

Published: 2012

Journal Articles

Phase II Safety and Efficacy Study of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma

Jason R. Westin, MD, Fuliang Chu, PhD, Luis E Fayad, MD, Larry W Kwak, MD, PhD, Nathan H Fowler, MD, Jorge E Romaguera, MD, F.B. Hagemeister, MD, Michelle Fanale, MD, Felipe Samaniego, M.D., Rochelle Allen, RN, Lei Feng, Ph.D, Veerabhadran Baladandayuthapani, PhD, Rinat Rotem-Yehudar, PhD, Sattva Neelapu, MD

Blood (2012) 120 (21): 793.

https://doi.org/10.1182/blood.V120.21.793.793

Published: 2012

Journal Articles

In Vitro and In Vivo Effects of CT-011, a Humanized Anti–PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas.

Fuliang Chu, PhD, Myriam Foglietta, MD, Hong Qin, MD, PhD, Rakesh Sharma, Ph.D., Qing Yi, MD, PhD, Galina Rodionov, Rinat Rotem-Yehudar, PhD, Sattva Neelapu, M.D.

Blood (2009) 114 (22): 724.

https://doi.org/10.1182/blood.V114.22.724.724

Published: 2009

Journal Articles

Blocking PD-1 in cancer immunotherapy

Gianpietro Dotti

Blood (2009) 114 (8): 1457–1458.

https://doi.org/10.1182/blood-2009-05-223412

Published: 2009

Journal Articles

PD-1 Expression Is Markedly Upregulated on Intratumoral CD4 + and CD8 + T Cells in Follicular Lymphoma and Is Associated with T-Cell Exhaustion.

Durgha Nattamai, Sattva S. Neelapu, MD

Blood (2007) 110 (11): 2749.

https://doi.org/10.1182/blood.V110.11.2749.2749

Published: 2007

Journal Articles

Thymic Recovery among Pediatric Stem Cell Recipients.

Helena Olkinuora, MD, Tanja Kaartinen, S.ch, Sanna Siitonen, MD, Kimmo Talvensaari, MD, Ulla Pihkala, MD, Kim Vettenranta, MD

Blood (2005) 106 (11): 1422.

https://doi.org/10.1182/blood.V106.11.1422.1422

Published: 2005

Journal Articles

Pediatric Patients Transplanted with Positive Selected Stem Cells from Alternative Donors Have a Low Incidence of CMV Dnaemia.

Peter Lang, MD, Klaus Hamprecht, MD, Johann Greil, MD, Peter Bader, MD, Hermann Einsele, MD, Friederike Neuheuser, Rupert Handgretinger, MD, Dietrich Niethammer, MD

Blood (2004) 104 (11): 5192.

https://doi.org/10.1182/blood.V104.11.5192.5192

Published: 2004

NARROW

Investigation of Cell-Contact Dependent Alterations in Immune Synapse Formation between T Cells and BCP-ALL Cells

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation

Hydroxyurea Is Most Suitable for Cytoreduction of AML Prior to CD33/CD3 Bispecific BiTE® Antibody (AMG 330) Therapy: Uncompromised T-Cell Proliferation Ex-Vivo and CD33 Upregulation on AML Cells

Immunological Effects and Predictive Gene Signatures in Patients with Relapsed Follicular Lymphoma Treated with CT-011, a Humanized Anti-PD-1 Monoclonal Antibody

Inhibitory Ligands CD200, CD270, CD274 and CD276 Are Expressed On Eμ-TCL1 Transgenic Mouse Splenocytes and Are of Potential Relevance to Impaired T-Cell Function in Vivo

Phase II Safety and Efficacy Study of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma

In Vitro and In Vivo Effects of CT-011, a Humanized Anti–PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas.

Blocking PD-1 in cancer immunotherapy

PD-1 Expression Is Markedly Upregulated on Intratumoral CD4 + and CD8 + T Cells in Follicular Lymphoma and Is Associated with T-Cell Exhaustion.

Thymic Recovery among Pediatric Stem Cell Recipients.

Pediatric Patients Transplanted with Positive Selected Stem Cells from Alternative Donors Have a Low Incidence of CMV Dnaemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only